Recent literature reported that the isoenzymes of LDH, including LDHA, LDHC, and LDHD, were significantly correlated with the clinical outcomes of RCC (Girgis et al., 2014; Hua et al., 2017; Wang et al., 2018; Zhao et al., 2017). Here, LDHC is linked to renal cell carcinoma.